2526 related articles for article (PubMed ID: 30417375)
1. Cancer stem cells (CSCs) in cancer progression and therapy.
Najafi M; Farhood B; Mortezaee K
J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
[TBL] [Abstract][Full Text] [Related]
2. Cancer stem cell (CSC) resistance drivers.
Najafi M; Mortezaee K; Majidpoor J
Life Sci; 2019 Oct; 234():116781. PubMed ID: 31430455
[TBL] [Abstract][Full Text] [Related]
3. Targeting signalling pathways and the immune microenvironment of cancer stem cells - a clinical update.
Clara JA; Monge C; Yang Y; Takebe N
Nat Rev Clin Oncol; 2020 Apr; 17(4):204-232. PubMed ID: 31792354
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia inducible factors in the tumor microenvironment as therapeutic targets of cancer stem cells.
Hajizadeh F; Okoye I; Esmaily M; Ghasemi Chaleshtari M; Masjedi A; Azizi G; Irandoust M; Ghalamfarsa G; Jadidi-Niaragh F
Life Sci; 2019 Nov; 237():116952. PubMed ID: 31622608
[TBL] [Abstract][Full Text] [Related]
5. Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target.
Yan Y; Zuo X; Wei D
Stem Cells Transl Med; 2015 Sep; 4(9):1033-43. PubMed ID: 26136504
[TBL] [Abstract][Full Text] [Related]
6. Targeting cancer stem cells and their niche: perspectives for future therapeutic targets and strategies.
Zhao Y; Dong Q; Li J; Zhang K; Qin J; Zhao J; Sun Q; Wang Z; Wartmann T; Jauch KW; Nelson PJ; Qin L; Bruns C
Semin Cancer Biol; 2018 Dec; 53():139-155. PubMed ID: 30081228
[TBL] [Abstract][Full Text] [Related]
7. Stem cell programs in cancer initiation, progression, and therapy resistance.
Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
[TBL] [Abstract][Full Text] [Related]
8. Targeting cancer stem cell pathways for cancer therapy.
Yang L; Shi P; Zhao G; Xu J; Peng W; Zhang J; Zhang G; Wang X; Dong Z; Chen F; Cui H
Signal Transduct Target Ther; 2020 Feb; 5(1):8. PubMed ID: 32296030
[TBL] [Abstract][Full Text] [Related]
9. Advances in Therapeutic Targeting of Cancer Stem Cells within the Tumor Microenvironment: An Updated Review.
Dzobo K; Senthebane DA; Ganz C; Thomford NE; Wonkam A; Dandara C
Cells; 2020 Aug; 9(8):. PubMed ID: 32823711
[TBL] [Abstract][Full Text] [Related]
10. Induction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation.
Lee SY; Jeong EK; Ju MK; Jeon HM; Kim MY; Kim CH; Park HG; Han SI; Kang HS
Mol Cancer; 2017 Jan; 16(1):10. PubMed ID: 28137309
[TBL] [Abstract][Full Text] [Related]
11. Cancer Stem Cells: Acquisition, Characteristics, Therapeutic Implications, Targeting Strategies and Future Prospects.
Yadav AK; Desai NS
Stem Cell Rev Rep; 2019 Jun; 15(3):331-355. PubMed ID: 30993589
[TBL] [Abstract][Full Text] [Related]
12. Canonical and non-canonical WNT signaling in cancer stem cells and their niches: Cellular heterogeneity, omics reprogramming, targeted therapy and tumor plasticity (Review).
Katoh M
Int J Oncol; 2017 Nov; 51(5):1357-1369. PubMed ID: 29048660
[TBL] [Abstract][Full Text] [Related]
13. Targeting CSCs within the tumor microenvironment for cancer therapy: a potential role of mesenchymal stem cells.
Bao B; Ahmad A; Li Y; Azmi AS; Ali S; Banerjee S; Kong D; Sarkar FH
Expert Opin Ther Targets; 2012 Oct; 16(10):1041-54. PubMed ID: 22877147
[TBL] [Abstract][Full Text] [Related]
14. Cancer stem cells and their niche in the progression of squamous cell carcinoma.
Oshimori N
Cancer Sci; 2020 Nov; 111(11):3985-3992. PubMed ID: 32888236
[TBL] [Abstract][Full Text] [Related]
15. Cancer stem cells.
Yu Z; Pestell TG; Lisanti MP; Pestell RG
Int J Biochem Cell Biol; 2012 Dec; 44(12):2144-51. PubMed ID: 22981632
[TBL] [Abstract][Full Text] [Related]
16. Cancer stem cells in immunoregulation and bypassing anti-checkpoint therapy.
Rouzbahani E; Majidpoor J; Najafi S; Mortezaee K
Biomed Pharmacother; 2022 Dec; 156():113906. PubMed ID: 36306594
[TBL] [Abstract][Full Text] [Related]
17. Cancer stem cell (a)symmetry & plasticity: Tumorigenesis and therapy relevance.
Najafi M; Mortezaee K; Ahadi R
Life Sci; 2019 Aug; 231():116520. PubMed ID: 31158379
[TBL] [Abstract][Full Text] [Related]
18. Evolving Strategies for Therapeutically Targeting Cancer Stem Cells.
Talukdar S; Emdad L; Das SK; Sarkar D; Fisher PB
Adv Cancer Res; 2016; 131():159-91. PubMed ID: 27451127
[TBL] [Abstract][Full Text] [Related]
19. The bad seed: Cancer stem cells in tumor development and resistance.
Koren E; Fuchs Y
Drug Resist Updat; 2016 Sep; 28():1-12. PubMed ID: 27620951
[TBL] [Abstract][Full Text] [Related]
20. Regulation and signaling pathways in cancer stem cells: implications for targeted therapy for cancer.
Zeng Z; Fu M; Hu Y; Wei Y; Wei X; Luo M
Mol Cancer; 2023 Oct; 22(1):172. PubMed ID: 37853437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]